Showing results (111-120 of 236) with videos related to

Sort By:
Pageof 24
Nature Medicine|August 13, 2002
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4)Bruce D Levy, George T De Sanctis, Pallavi R Devchand, et al.
The Journal of Allergy and Clinical Immunology|September 3, 2025
Traffic-emitted ultrafine particles disrupt macrophage efferocytosis and resolution of allergic lung inflammationThayse R Brüggemann, Luciana P Tavares, Nicole Almanzar, et al.
Environmental Health Perspectives|July 30, 2016
IL-33 Drives Augmented Responses to Ozone in Obese MiceJoel A Mathews, Nandini Krishnamoorthy, David Itiro Kasahara, et al.
Lab on a Chip|January 16, 2016
Broad spectrum immunomodulation using biomimetic blood cell margination for sepsis therapyHan Wei Hou, Lidan Wu, Diana P Amador-Munoz, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Early neutrophil and persistent eosinophil-associated gene signature in childhood asthmaFrancesco Foppiano, Andreas Böck, Claudia Beerweiler, et al.
American Journal of Respiratory Cell and Molecular Biology|August 8, 2023
Eosinophil Phenotypes Are Functionally Regulated by Resolvin D2 during Allergic Lung InflammationThayse R Brüggemann, Hong Yong Peh, Luciana P Tavares, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 28, 2010
The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejectionBruce D Levy, Qing-yin Zhang, Caroline Bonnans, et al.
Science Advances|September 8, 2018
PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivoCatherine A Loynes, Jou A Lee, Anne L Robertson, et al.
Annals of Intensive Care|March 9, 2022
Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumoniaGuillaume Eberst, Fréderic Claudé, Lucie Laurent, et al.
Science Translational Medicine|October 9, 2024
An altered natural killer cell immunophenotype characterizes clinically severe pediatric RSV infectionRoisin B Reilly, Saïsha K Ramdour, Mary E Fuhlbrigge, et al.
Pageof 24